CRISPR Therapeutics (UK) Market Value
| 0VRQ Stock | 60.18 7.10 13.38% |
| Symbol | CRISPR |
CRISPR Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CRISPR Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CRISPR Therapeutics.
| 12/23/2025 |
| 01/22/2026 |
If you would invest 0.00 in CRISPR Therapeutics on December 23, 2025 and sell it all today you would earn a total of 0.00 from holding CRISPR Therapeutics AG or generate 0.0% return on investment in CRISPR Therapeutics over 30 days. CRISPR Therapeutics is related to or competes with Planet Fitness, National Beverage, Ebro Foods, Bellevue Healthcare, AMG Advanced, Optima Health, and Worldwide Healthcare. CRISPR Therapeutics is entity of United Kingdom More
CRISPR Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CRISPR Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CRISPR Therapeutics AG upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.63 | |||
| Information Ratio | 0.0029 | |||
| Maximum Drawdown | 13.34 | |||
| Value At Risk | (4.69) | |||
| Potential Upside | 5.69 |
CRISPR Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CRISPR Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CRISPR Therapeutics' standard deviation. In reality, there are many statistical measures that can use CRISPR Therapeutics historical prices to predict the future CRISPR Therapeutics' volatility.| Risk Adjusted Performance | 0.0353 | |||
| Jensen Alpha | 0.0522 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.0033 | |||
| Treynor Ratio | 0.1912 |
CRISPR Therapeutics Backtested Returns
CRISPR Therapeutics appears to be very steady, given 3 months investment horizon. CRISPR Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of return volatility over the last 3 months. We have found twenty-nine technical indicators for CRISPR Therapeutics AG, which you can use to evaluate the volatility of the firm. Please makes use of CRISPR Therapeutics' Risk Adjusted Performance of 0.0353, semi deviation of 2.33, and Mean Deviation of 2.18 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, CRISPR Therapeutics holds a performance score of 10. The firm shows a Beta (market volatility) of 0.53, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CRISPR Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding CRISPR Therapeutics is expected to be smaller as well. Please check CRISPR Therapeutics' semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether CRISPR Therapeutics' price patterns will revert.
Auto-correlation | -0.15 |
Insignificant reverse predictability
CRISPR Therapeutics AG has insignificant reverse predictability. Overlapping area represents the amount of predictability between CRISPR Therapeutics time series from 23rd of December 2025 to 7th of January 2026 and 7th of January 2026 to 22nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CRISPR Therapeutics price movement. The serial correlation of -0.15 indicates that less than 15.0% of current CRISPR Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.15 | |
| Spearman Rank Test | 0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 2.1 |
CRISPR Therapeutics lagged returns against current returns
Autocorrelation, which is CRISPR Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CRISPR Therapeutics' stock expected returns. We can calculate the autocorrelation of CRISPR Therapeutics returns to help us make a trade decision. For example, suppose you find that CRISPR Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CRISPR Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CRISPR Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CRISPR Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CRISPR Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
CRISPR Therapeutics Lagged Returns
When evaluating CRISPR Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CRISPR Therapeutics stock have on its future price. CRISPR Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CRISPR Therapeutics autocorrelation shows the relationship between CRISPR Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in CRISPR Therapeutics AG.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CRISPR Stock Analysis
When running CRISPR Therapeutics' price analysis, check to measure CRISPR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CRISPR Therapeutics is operating at the current time. Most of CRISPR Therapeutics' value examination focuses on studying past and present price action to predict the probability of CRISPR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CRISPR Therapeutics' price. Additionally, you may evaluate how the addition of CRISPR Therapeutics to your portfolios can decrease your overall portfolio volatility.